세계의 FSP(Functional Service Provider) 시장 규모 조사 : 유형별, 단계별, 용도별 및 지역별 예측(2022-2032년)

The global functional service providers (FSP) market was valued at approximately USD 14.43 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.49% from 2024 to 2032. Functional service providers offer critical support to biopharmaceutical and biotechnology companies by providing a skilled workforce for various clinical development and post-approval activities. The outsourcing of these functions allows companies to focus on their core competencies, reduce operational costs, and improve efficiency in drug development processes. The market growth is driven by the increasing R&D investments and the rising number of clinical trials. Furthermore, the adoption of advanced technologies, such as artificial intelligence, machine learning, and big data analytics, is enhancing the capabilities of FSPs. These technologies streamline processes, improve data accuracy, and enable more efficient trial management.

The increasing adoption of FSPs is largely due to their ability to turn fixed costs into variable costs without compromising on quality or control. The US biopharmaceutical industry, which has been a global leader for over 30 years, invests significantly in R&D, contributing to the demand for functional service providers. Additionally, the rise in clinical trials and the need for specialized services are driving the market growth. Furthermore, the growing complexity and cost of clinical trials further fuel the demand for FSPs, which provide solutions such as clinical monitoring, data management, statistical programming, and medical writing. However, high cost and complex nature of clinical trials and issues with integrating new technologies restrain growth for the Global Functional Service Providers Market during the forecast period 2024-2032.

The key region in the Global Functional Service Providers Market includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2023, North America dominates the market in terms of revenue due to its advanced healthcare infrastructure, significant investment in pharmaceutical and biotechnology research, and high demand for specialized clinical services. The region's well-established network of major pharmaceutical companies and clinical research organizations drives the adoption of FSP solutions. Additionally, North America's stringent regulatory standards and emphasis on innovative clinical practices contribute to its market leadership. The growing complexity of clinical trials and a focus on operational efficiency further enhance the region's prominence, making it a key player in the global FSP market. Furthermore, Asia-Pacific is expected to witness the highest growth rate, driven by factors such as a high patient population, lower costs of conducting trials, and favourable regulatory policies.

Major market players included in this report are:

• IQVIA Inc. (US)
• Parexel International Corporation (US)
• Laboratory Corporation of America Holdings (US)
• Icon Plc (Ireland)
• PPD Inc. (US)
• Quanticate International Limited (UK)
• BioPoint Inc. (US)
• RHO, Inc. (US)
• Wuxi AppTec Co., Ltd. (China)
• KPS Life, LLC (US)

The detailed segments and sub-segment of the market are explained below:

By Type

• Clinical Monitoring
• Medical Writing
• Data Management
• Pharmacovigilance
• Biostatistics
• Programming
• Study Design
• Others

By Stage

• Clinical Development
• Post Approval

By Application

• Biopharma Companies
• Biotech Companies
• Medical Devices Companies

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Functional Service Providers Market Executive Summary

• 1.1. Global Functional Service Providers Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Type
  • 1.3.2. By Stage
  • 1.3.3. By Application
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Functional Service Providers Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Functional Service Providers Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Increasing R&D investments
  • 3.1.2. Rising number of clinical trials
• 3.2. Market Challenges
  • 3.2.1. High cost and complex nature of clinical trials
  • 3.2.2. Issues with integrating new technologies
• 3.3. Market Opportunities
  • 3.3.1. Expansion of FSPs in emerging markets
  • 3.3.2. Integration of advanced technologies such as AI and machine learning

Chapter 4. Global Functional Service Providers Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top Investment Opportunity
• 4.4. Top Winning Strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Functional Service Providers Market Size & Forecasts by Type 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Functional Service Providers Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Clinical Monitoring
  • 5.2.2. Medical Writing
  • 5.2.3. Data Management
  • 5.2.4. Pharmacovigilance
  • 5.2.5. Biostatistics
  • 5.2.6. Programming
  • 5.2.7. Study Design
  • 5.2.8. Others

Chapter 6. Global Functional Service Providers Market Size & Forecasts by Stage 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Functional Service Providers Market: Stage Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Clinical Development
  • 6.2.2. Post Approval

Chapter 7. Global Functional Service Providers Market Size & Forecasts by Application 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Functional Service Providers Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Biopharma Companies
  • 7.2.2. Biotech Companies
  • 7.2.3. Medical Devices Companies

Chapter 8. Global Functional Service Providers Market Size & Forecasts by Region 2022-2032

• 8.1. North America Functional Service Providers Market
  • 8.1.1. U.S. Functional Service Providers Market
    • 8.1.1.1. Type breakdown size & forecasts, 2022-2032
    • 8.1.1.2. Stage breakdown size & forecasts, 2022-2032
    • 8.1.1.3. Application breakdown size & forecasts, 2022-2032
  • 8.1.2. Canada Functional Service Providers Market
• 8.2. Europe Functional Service Providers Market
  • 8.2.1. U.K. Functional Service Providers Market
  • 8.2.2. Germany Functional Service Providers Market
  • 8.2.3. France Functional Service Providers Market
  • 8.2.4. Spain Functional Service Providers Market
  • 8.2.5. Italy Functional Service Providers Market
  • 8.2.6. Rest of Europe Functional Service Providers Market
• 8.3. Asia-Pacific Functional Service Providers Market
  • 8.3.1. China Functional Service Providers Market
  • 8.3.2. India Functional Service Providers Market
  • 8.3.3. Japan Functional Service Providers Market
  • 8.3.4. Australia Functional Service Providers Market
  • 8.3.5. South Korea Functional Service Providers Market
  • 8.3.6. Rest of Asia Pacific Functional Service Providers Market
• 8.4. Latin America Functional Service Providers Market
  • 8.4.1. Brazil Functional Service Providers Market
  • 8.4.2. Mexico Functional Service Providers Market
  • 8.4.3. Rest of Latin America Functional Service Providers Market
• 8.5. Middle East & Africa Functional Service Providers Market
  • 8.5.1. Saudi Arabia Functional Service Providers Market
  • 8.5.2. South Africa Functional Service Providers Market
  • 8.5.3. Rest of Middle East & Africa Functional Service Providers Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Icon Plc (Ireland)
  • 9.3.2. PPD Inc. (US)
  • 9.3.3. Quanticate International Limited (UK)
  • 9.3.4. BioPoint Inc. (US)
  • 9.3.5. RHO, Inc. (US)
  • 9.3.6. Wuxi AppTec Co., Ltd. (China)
  • 9.3.7. KPS Life, LLC (US)
  • 9.3.8. IQVIA Inc. (US)
  • 9.3.9. Laboratory Corporation of America Holdings (US)
  • 9.3.10. Parexel International Corporation (US)

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes